R3: cost and payments to doctors
What Medicare Part D paid pharmacies for R3, and the payments that named it as the associated device or medical supply under the Sunshine Act for program years 2019–2025.
Was your doctor paid by Smith+Nephew?
Smith+Nephew reported the most payments naming R3. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $628K
- Providers
- 240
- Transactions
- 524
- Average per transaction
- $1,198
The per-transaction average — $1,198 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 240 providers the average total is $2,615, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Smith+Nephew | $627,539 | 100.0% |
Other products from Smith+Nephew
The company that reported the most payments naming R3 also reports against these.
- Journey II$49,222,295
- Engage Partial Knee System$43,525,192
- EVOS$39,210,041
- TRIGEN InterTAN$20,250,975
- REAL INTELLIGENCE$20,227,275
- Q-FIX$18,455,719
- Journey II BCS$11,128,986
- Healicoil$10,632,451
- TRIGEN Femoral (FAN/TAN/Meta Nail)$8,908,003
- FOOTPRINT$7,470,438